Cellply is developing a revolutionary analytical platform for immune cell profiling of cellular function required in cell therapy and antibody development.
The Cellply Co-Culture Array (CCATM) technology offers a dramatically improved understanding of cell function at the single cell level with applicability across all stages of R&D into clinical development and manufacturing.
Contact us today to understand how we combine robotics, CCATM microfluidics and AI to significantly reduce your time to market at lower costs with less risk of failure.


Cellply is involved in a limited number of selected collaborations with biopharma and clinical research institutes developing cell therapies and immunotherapies.
If you are interested in exploring a collaboration with us, please click on the button below.



Massimo Bocchi, PhD

CEO and Co-founder

Massimo received a Ph.D. in Electrical Engineering from the University of Bologna in 2006 and a Technology Entrepreneurship Certificate from the Leavey School of Business, Santa Clara University, CA in 2010. He has 10 years of research experience on microelectronics and microsystems for life science applications with 30 publications appeared on international scientific journals, such as the Technology Review Magazine from MIT. He is inventor of 4 patent families in the fields of microtechnologies for cell manipulation and innovative methods for drug discovery. In 2009, after developing a business idea based on the technology currently under development at Cellply, he obtained a grant (1st rank) from the Fulbright Commission for a period of study and work in Silicon Valley. In 2011 he co-founded the Italian Institute for Entrepreneurship, a no-profit organization promoting initiatives for the growth of an entrepreneurship-based ecosystem in Italy.

Roberto Guerrieri, PhD

Co-founder at CellPly

Roberto is Full Professor in Electrical Engineering at the University of Bologna and serial entrepreneur. He received the Electrical Engineering degree and the Ph.D. from the University of Bologna. From 1986, he has been visiting the Dept. of EECS at the University of California at Berkeley and the Dept. of Electrical Engineering at the MIT in Boston. In 1998 he became Director of the Laboratory for Electronic Systems, a joint venture of the University of Bologna and STM Microelectronics. He is senior founder of Silicon Biosystems, a biomedical device company (Exit with Menarini Spa), and tech inventor of the fingerprint sensor developed at Upek, Inc and integrated on the Iphone (Exit with Apple). Roberto published 90+ papers in various fields including numerical simulation, electronics, computer science, biometric sensors and applications of microelectronic to biotechnology. He has been awarded a Best Paper Award of the IEEE Transactions on Semiconductor Manufacturing and an “ISSCC Best Paper Award” for his work on biosensor system design.




Schia Ventures nel capitale di CellPly

PRESS RELEASE La SPV costituita da un gruppo di investitori di area parmigiana rafforza il round di una delle aziende più all’avanguardia nel […]


Two million Euro round for Cellply to revolutionize the characterization of cell therapies

PRESS RELEASE LIFTT, IAG partners, Indaco, Meta Ventures and Recomec invest in CellPly The objective of the investment is to bring to market […]


L’innovazione Cellply in un articolo sulla rivista Le Scienze

Cliccare sull’immagine in basso per visualizzare l’articolo


Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting

Bologna (Italy), 25 November 2019. Cellply announced today that the company will present an abstract with new results about its novel Inter-Cell Networking […]


Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.


CellPly s.r.l.
Via Giuseppe Massarenti 61
40138 Bologna


CellPly s.r.l.
Via Fondazza 53
40125 Bologna


Phone: +39 051 0397670
Fax: +39 051 0420705
e-mail: info@cellply.com